Risk of falls and fractures in older adults using antipsychotic agents: A propensity-matched retrospective cohort study

Drugs and Aging

Volumn 27, Issue 10, 2010, Pages 815-829

  Mehta, Sandhya ^a   Chen, Hua ^a   Johnson, Michael L ^a   Aparasu, Rajender R ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Antipsychotics; Elderly; Fracture; Injuries; Therapeutic use

Indexed keywords

ACETOPHENAZINE; AMITRIPTYLINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CHLORPROTHIXENE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PERPHENAZINE; PIMOZIDE; PROCHLORPERAZINE; PROMAZINE; QUETIAPINE; RISPERIDONE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; ZIPRASIDONE;

AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY LIVING; EMERGENCY WARD; EVALUATION; FALL RISK ASSESSMENT; FALLING; FEMALE; FEMUR FRACTURE; FOLLOW UP; FRACTURE; HIP FRACTURE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TREATMENT DURATION; UNITED STATES;

ACCIDENTAL FALLS; ADULT; AGED; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; EMERGENCY SERVICE, HOSPITAL; FRACTURES, BONE; HOSPITALIZATION; HUMANS; RETROSPECTIVE STUDIES; RISK;

EID: 77957723856     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11537890-000000000-00000     Document Type: Article

References (50)

1. Research Activities. Outcomes/effectiveness research: evidence is lacking to support many off-label uses of atypical antipsychotic drugs. 2007 Feb [online]. Available from URL: http://www.ahrq.gov/research/feb07/0207RA18.htm [Accessed 2009 Apr 16]
2. Jano E, Chen H, Johnson ML, et al. Antipsychotic utilization and expenditure trends among elderly persons. Psy-chiatr Serv 2007 Nov; 58 (11): 1400
3. Aparasu RR, Bhatara V, Gupta S. U.S. national trends in the use of antipsychotics during office visits, 1998-2002. Ann Clin Psychiatry 2005; 17 (3): 147-52
4. Cumming RG. Epidemiology of medication-related falls and fractures in the elderly. Drugs Aging 1998 Jan; 12 (1): 43-53
5. Hartikainen S, Lonnroos E, Louhivuori K. Medication as a risk factor for falls: critical systematic review. J Gerontol 2007; 62A (10): 1172-81
6. French DD, Campbell R, Spehar A, et al. Outpatient medications and hip fractures in the US: a national veterans study. Drugs Aging 2006; 22 (10): 877-85
7. Busche C, Shaw M, Peveler RC. A review of the association between antipsychotic use and hyperprolactinaemia. J Psychopharmacol 2008 Mar; 22 (2 Suppl.): 46-55
8. Miller DD. Atypical antipsychotics: sleep, sedation and efficacy. J Clin Psychiatry 2004; 6 Suppl. 2: 3-7
9. Naidoo U, GoffDC, Klibanski A. Hyperprolactinemia and bone mineral density: the potential impact ofantipsychotic agents. Psychoneuroendocrinology 2003; 28: 97-108
10. Akyol AD. Falls in the elderly: what can be done? Int Nurs Rev 2007; 54: 191-6
11. Hayes WC, Myers ER, Morris JN, et al. Impact near the hip dominates fracture risk in elderly nursing home residents who fall. CalcifTissue Int 1993; 52: 192-8
12. Hugenholtz GW, Heerdink ER, Staa TP, et al. Risk of hip/femur fractures in patients using antipsychotics. Bone 2005; 37: 864-70
13. Liperoti R, Onder G, Lapane KL, et al. Conventional or atypical antipsychotics and the risk of femur fracture among elderly patients: results of a case-control study. J Clin Psychiatr 2007; 68: 929-34
14. Pouwels S, Staa TP, Egberts ACG. Antipsychotic use and the risk of hip/femur fracture: a population-based case-control study. Osteoporosis Int 2009 Sep; 20 (9): 1499-506
15. Landi F, Onder G, Cesari M, et al. Psychotropic medications and risk of falls among community-dwelling frail older people: an observational study. J Gerontol 2005; 60A (5): 622-6
16. Hein LTT, Cumming RG, Cameron ID, et al. Atypical antipsychotic medications and risk of falls in residents of aged care facilities. J Am Geriatr Soc 2005; 53: 1290-5
17. Katz IR, Rupnow M, Kozma C, et al. Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind placebo-controlled trial. Am J Geriatr Psychiatry 2004; 12: 499-508
18. Takkouche B, Montes-Martinez A, Gill SS, et al. Psychotropic medications and the risk offracture: a metaanalysis. Drug Saf2007; 30 (2): 171-84
19. Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and risk of hip fractures. N Engl J Med 1987; 316 (7): 363-9
20. Mustard CA, Mayer T. Case-control study of exposure to medication and the risk of injurious falls requiring hospi-talization among nursing home residents. Am J Epidemiol 1997; 145: 738-45
21. Vitry AI, Hoile AP, Andrew LG, et al. The risk of falls and fractures associated with persistent use of psychotropic medications in elderly people. Arch Gerontol Geriatr 2010; 50 (3): e1-4
22. Bolton JM, Metge C, Lix L, et al. Fracture risk from psychotropic medications: a population-based analysis. J Clin Psychopharmacol 2008; 28 (4): 384-91
23. Vestergaard P, Rejnmark L, Mosekilde L. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of frac-ture. Osteoporosis Int 2006; 17: 807-16
24. Thapa PB, Gideon P, Fought RL, et al. Psychotropic drugs and risk of recurrent falls in ambulatory nursing home re-sidents. Am J Epidemiol 1995; 142 (2): 202-11
25. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and metaanalysis, 1. Psychotropic drugs. J Am Geriatr Soc 1999; 47: 30-9
26. World Health Organization. ICD-9: international statistical classification of diseases and related health problems. 9th rev. Geneva: World Health Organization, 1978
27. PharMetrics® Integrated Database. Data assets. IMS [online]. Available from URL: http://www.imshealth.com/portal/site/imshealth/menuitem. a46c6d4df3db4b3d88f611019418c 22a/?vgnextoid=6d7660b6f5aa0210VgnVCM100000ed152ca 2RCRD&vgnextchannel=bc42650204850210VgnVCM10000 0ed152ca2RCRD& vgnextfmt=default [Accessed 2009 Oct 24]
28. Valuck RJ, Libby AM, Sills MR, et al. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospec-tive cohort study. CNS Drugs 2004; 18 (15): 1119-32
29. Gill SS, Bronskill SE, Normand SLT, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007; 146: 775-86
30. Schneeweiss S, Setoguchi S, Brookhart A, et al. Risk of death associated with the use of conventional versus aty-pical antipsychotic drugs among elderly patients. CMAJ 2007; 176 (5): 627-32
31. Elixhauser A, Steiner CA, Whittington CA, et al. Clinical classifications for health policy research: hospital inpatient statistics, 1995. Healthcare Cost and Utilization project, HCUP-3 research note. Rockville (MD): Agency for Healthcare Research and Quality, 2000. AHCPR Pub. No. 98-0049
32. Grobee DE. Confounding and indication for treatment in evaluation ofdrug treatment for hypertension. BMJ 1997; 315: 1151-4
33. Baser O. Too much ado about propensity score models? Comparing methods ofpropensity score matching. Value Health 2006; 9 (6): 377-85
34. Brookhart MA, Schneeweiss S, Rothman KJ, et al. Variable selection for propensity score models. Am J Epidemiol 2006; 163 (12): 1149-56
35. Aparasu RR, Jano E, Johnson ML, et al. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Am J Geriatr Pharmacother 2008; 6: 198-204
36. Parson LS. Reducing bias in a propensity score matchedpair sample using greedy matching techniques [online]. Available from URL: http://www2.sas.com/ proceedings/sugi26/p214-26.pdf[Accessed 2009 Mar 30]
37. Feng WW, Jun Y, Plaines D, et al. A method/macro based on propensity score and Mahalanobis distance to reduce bias in treatment comparison in observational study [on-line]. Available from URL: http://www.lexjansen.com/phar masug/2006/publichealthresearch/pr05.pdf [Accessed 2009 Apr 7]
38. Alexander MT, Kufera JA. Butting heads on matched cohort analysis using SAS software [online]. Available from URL: http://www.nesug.org/proceedings/ nesug07/sa/sa01.pdf [Accessed 2009 May 1]
39. Austin PC Type I error rates, coverage of confidence intervals, and variance estimation in propensity-score match-ed analysis. Int J Biostat 2009; 5 (1): 1-21
40. Leslie RS. Calculating medication compliance, adherence, and persistence in administrative pharmacy claims database [online]. Available from URL: http://www.wuss.org/proce edings08/08WUSS%20Proceedings/papers/anl/anl09.pdf [Ac-cessed 2009 Apr 12]
41. Wang PS, Schneeweiss S, Setoguchi S, et al. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol 2007; 27 (6): 707-10
42. Dehejia RH, Wahba S. Propensity score-matching for nonexperimental causal studies. Rev Econ Stat 2002; 84 (1): 151-61
43. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70 (1): 41-55
44. Meltzer HY, Matsubara S, Lee JC. Classification oftypical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin-2 pKi values. Am Soc Pharmacol Exp Ther 1989; 251 (1): 238-46
45. Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizo-phrenia: ametaanalysis. Lancet2009; 373: 31-41
46. Burns MJ. The pharmacology and toxicology of atypical antipsychotic agents. J Toxicol Clin Toxicol 2001; 39: 1-14
47. Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and metaanalysis. I: psychotropic drugs. J Am Geriatr Soc 1999 Jan; 47 (1): 30-9
48. French DD, Campbell R, Spehar A, et al. Drugs and falls in community-dwelling older people: a national veterans study. Clin Ther 2006; 28 (4): 619-30
49. Cooper JW. Falls and fractures in nursing home patients receiving psychotropic drugs. Int J Geriatr Psychiatry 1994; 9: 975-80
50. 2010 National patient safety goals [online]. Available from URL: http://www.jointcommission.org/patientsafety/national patientsafetygoals/ [Accessed 2010 Feb 22]